ORIGINAL RESEARCH article
Front. Oncol., 24 September 2020
Sec. Cancer Molecular Targets and Therapeutics
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.533176
RETRACTED: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation
- HQ
Hongbo Qu 1*
- FZ
Fang Zhu 2
- HD
Huaying Dong 3
- XH
Xiongqiang Hu 1
- MH
Mingli Han 4
1. Department of Breast and Thyroid Surgery, The First People's Hospital of Chenzhou, Chenzhou, China
2. Department of Breast Health Center, The First People's Hospital of Chenzhou (South Hospital), Chenzhou, China
3. Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou, China
4. Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Summary
Citation
Qu H, Zhu F, Dong H, Hu X and Han M (2020) RETRACTED: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation. Front. Oncol. 10:533176. doi: 10.3389/fonc.2020.533176
Received
30 March 2020
Accepted
18 August 2020
Published
24 September 2020
Volume
10 - 2020
Edited by
Marie R. Webster, Lankenau Institute for Medical Research, United States
Reviewed by
Yogesh Chawla, Mayo Clinic, United States; Hailin Tang, Sun Yat-sen University Cancer Center (SYSUCC), China
Updates
This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.